A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study
| Autor: | Daniel M. Witt, Cassidy Jennings, Stacy A. Johnson, Elizabeth Young, Aubrey E. Jones, Ryan P. Fleming, Kelsey Simon |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
musculoskeletal diseases
medicine.medical_specialty medicine.medical_treatment Arthroplasty Replacement Hip Total hip replacement Cohort Studies Postoperative Complications Internal medicine medicine Humans cardiovascular diseases Arthroplasty Replacement Knee Retrospective Studies Aspirin business.industry Hazard ratio Warfarin Anticoagulants Retrospective cohort study Hematology Venous Thromboembolism musculoskeletal system equipment and supplies Arthroplasty surgical procedures operative business Venous thromboembolism medicine.drug Cohort study |
| Zdroj: | Thrombosis research. 206 |
| ISSN: | 1879-2472 |
| Popis: | Introduction Venous thromboembolism (VTE) and bleeding events following total knee and hip arthroplasty (TKA/THA) are associated with significant morbidity. Clinical guidelines recommend administration of pharmacologic VTE prophylaxis post-operatively, although controversy exists regarding optimal prophylactic strategies. Methods We performed a retrospective cohort study in patients who underwent elective TKA/TKA in an academic medical center. Patients were stratified by surgery type (TKA/THA) and VTE risk determined by a novel risk stratification protocol and compared pre- and post-protocol implementation. Patients received warfarin pre-protocol and either aspirin or warfarin post-protocol for VTE prophylaxis. Natural language processing identified VTE events and ICD codes were used to identify bleeding events, with all events validated manually. Results A total of 1379 surgeries were included for analysis, 839 TKAs and 540 THAs. Post-protocol implementation, 445 (94.1%) patients following TKA and 294 (97.4%) patients following THA received aspirin for VTE prophylaxis. A significant reduction in bleeding events (hazard ratio [HR] = 0.19, p = 0.048) was observed in low-risk THA patients treated with aspirin (post-protocol) compared patients treated with warfarin (pre-protocol). Bleeding events did not differ significantly between low-risk TKA patients treated with aspirin or warfarin. No significant differences in VTE events were observed following the protocol implementation. Conclusions The use of a novel risk stratification system to guide VTE prophylaxis selection between aspirin or warfarin following TKA and THA appears safe and effective. Among low-risk patients, aspirin use was associated with fewer bleeding events following THA, without an observed increase in VTE events. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect